Abstract: Substantial improvements in photorefractive device lifetimes are provided by control of electron migration which results in the decay of gratings in photorefractive materials due to diffusion and other effects. A new class of photorefractive devices using compensating electronic and ionic gratings having relatively low efficiency but nonetheless usable gratings is provided by arranging the gratings to be reflective in a wavelength band outside the photo-excitation band of the photorefractive material, as by using an infrared operating wavelength. Longer lifetimes in high efficiency gratings are achieved by constant or periodic illumination of photorefractive materials to assure uniform charged distribution of electrons and maintenance of the ionic backbone grating.
Type:
Grant
Filed:
April 13, 1995
Date of Patent:
August 18, 1998
Assignee:
Accuwave Corporation
Inventors:
George Anthony Rakuljic, Victor Leyva, Amnon Yariv, Koichi Sayano, Arthur Bruce O'Connor, Charles E. Tyler, Xiaoping Mao, Harold Everett Miller, Jr.
Abstract: A beverage cup includes an inner vessel having walls defining a fluid retaining volume. An outer wall surrounds the inner vessel and cooperates with the inner vessel to define an enclosed chamber. A microwave receptive material is disposed within the enclosed chamber.
Abstract: A method for forming a metal interconnection capable of minimizing plasma etching damage on a metal layer having a relatively higher step when forming a via hole.
Abstract: The present invention relates to a process of making a concentrate of coagulation proteins starting with whole human or animal plasma. This concentrate is used as a biological adhesive when extemporaneously mixed to thrombin. The concentrated proteins include mostly fibrinogen, fibrin stabilizing factor (factor XIII) and fibronectin. The claimed process has the advantage of being short of execution while providing an excellent yield of coagulable proteins. No protease inhibitor has to be added during the process. The process involves steps of separation by "salting-out" in presence of amino-6 hexanoic acid which prevents co-precipitation of plasminogen with the desired coagulable proteins. The proteins so obtained are very stable after reconstitution in water for at least 24 hours at room or body temperature. After mixing with thrombin and calcium, the adhesive shows excellent strength and biocompatibility.
Type:
Grant
Filed:
February 23, 1993
Date of Patent:
March 7, 1995
Assignee:
Haemacure-Biotech, Inc.
Inventors:
Trung Bui-Khac, Lise Lavoie, Dominique Michel St Picq